StockWatch
·

Vivos Therapeutics, Inc.

Ticker: 1716166

Board Meeting in 10 days

P/L Snapshot

Q3 FY26 · consolidated

vs Q2 FY26·vs Q3 FY25
Revenue
6.41
+24.5%-5.5%
Expenditure
10.31
+3.3%-10.5%
Net Profit
-1.95
+64.4%+63.9%
OPM %
-60.74%
+32.89pp+9.05pp

Shareholding

Pattern breakdown

P/L Trends

(in millions)

RevenueExpenditureNet Profit
-10.01-3.992.048.0714.09Q3 FY23Q1 FY24Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26
Price Chart
Latest News